HIV and AIDS: 20 years of science

@article{Fauci2003HIVAA,
  title={HIV and AIDS: 20 years of science},
  author={Anthony S. Fauci},
  journal={Nature Medicine},
  year={2003},
  volume={9},
  pages={839-843}
}
  • A. Fauci
  • Published 2003
  • Medicine
  • Nature Medicine
From the identification of HIV as the agent that causes AIDS, to the development of effective antiretroviral drugs, the scientific achievements in HIV research in the past 20 years have been formidable. Some of the other important areas of accomplishment include the development of blood tests for HIV and increased knowledge of the molecular virology, epidemiology and pathogenesis of this virus. 
25 Years of HIV/AIDS Science: Reaching the Poor with Research Advances
TLDR
Although much has been accomplished in HIV/AIDS research, much remains to be done, especially regarding delivery of HIV/ AIDS therapies and care and prevention interventions to the poorest countries that need them most. Expand
HIV and AIDS: looking ahead
  • R. Weiss
  • Biology, Medicine
  • Nature Medicine
  • 2003
Although the future of HIV science is uncertain, we need to reappraise HIV diversity, pathogenesis and immunity. The AIDS pandemic threatens the success of existing vaccine programs and mayExpand
HIV/AIDS: Here to stay for a long time
  • E. Tramont
  • Medicine
  • Current infectious disease reports
  • 2005
TLDR
Despite the rapid increase in knowledge regarding the epidemiology, pathogenesis, and molecular virology of HIV-1 and the continued advances in chemotherapy, HIV/AIDS will be with us for a long time to come and is winning the host-pathogen battle. Expand
The current status of, and challenges in, the development of CCR5 inhibitors as therapeutics for HIV-1 infection.
TLDR
There is a cautious optimism that several CCR5 inhibitors might soon be added to the armamentarium for therapy of HIV-1 infection. Expand
Blocking viral entry: a complementary strategy for HIV therapy
Applications of current antiretroviral drugs, including reverse transcriptase and protease inhibitors, have significantly increased life expectancy for HIV-infected individuals. However, increasingExpand
Twenty-six years of HIV science: an overview of anti-HIV drugs metabolism
TLDR
An overview of the metabolism of currently available anti-HIV drugs is described, which shows that formation of active or toxic metabolites will have an impact on the pharmacological and toxicological outcomes. Expand
Development of therapeutics for AIDS: structure-based molecular targeting.
TLDR
The challenges encountered in realizing the optimal benefits of the newer therapeutics to individuals with AIDS and HIV-1 infection receiving highly active antiretroviral therapy (HAART) are dealt with. Expand
The Global HIV/AIDS Vaccine Enterprise: Scientific Strategic Plan
TLDR
A new international collaboration shares its plan to address the challenge of developing an HIV vaccine and the challenges faced by scientists in developing and implementing such a vaccine. Expand
To Review the Pathogenesis, traditional Treatment and Future Trends in the Diagnosis and Treatment of HIV Infections
TLDR
The HIV infection has a major role in the human immunodeficiency syndrome and the main factor is the reduction of CD4 cells and increment in the growth of B-cells with hypergammaglobulinamia. Expand
Immunologic features of HIV‐1‐infected women on HAART at delivery
The conjoint effect of HIV infection and pregnancy on the immune system of women submitted to the prophylactic antiretroviral therapy presently recommended is still poorly understood.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 58 REFERENCES
The Early Years of HIV/AIDS
TLDR
A view of the frustrations and triumphs that led to the discovery of HIV as the cause of AIDS is provided by an insider of the Insitute of Human Virology in Baltimore, Maryland. Expand
A History of HIV Discovery
TLDR
It is almost 20 years since HIV was first isolated and identified as the cause of AIDS and Montagnier's Viewpoint provides fresh insights into the frustrations and triumphs of the discovery of HIV, seen through the eyes of the French virologist whose team first identified this new human retrovirus. Expand
Host factors and the pathogenesis of HIV-induced disease
The level of human immunodeficiency virus (HIV) replication in patients reflects a balance between stimulatory and inhibitory host factors (particularly endogenous cytokines). New informationExpand
Challenges and opportunities for development of an AIDS vaccine
TLDR
The biomedical community is looking towards vaccines to help solve this compelling problem of considerable expense and logistical difficulty in providing antiviral drugs to populations infected with the human immunodeficiency virus throughout the world. Expand
HIV-1 superinfection--a word of caution.
TLDR
A large number of patients diagnosed with HIV-1 infection during the initial symptomatic period did not have any known underlying cause of infection, and the prognosis was generally good. Expand
Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy
TLDR
The dynamic interplay of host cell and virus is essential to the effort to eradicate HIV and this work helps us to understand this interplay in a more effective manner. Expand
AIDS pathogenesis: what have two decades of HIV research taught us?
22 years ago, the first cases of an acquired immunodeficiency syndrome afflicting young, homosexual American men were reported, heralding what we now know to be the beginning of the HIV epidemic.Expand
The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.
Infection with the human immunodeficiency virus (HIV) results in a profound immunosuppression due predominantly to a selective depletion of helper/inducer T lymphocytes that express the receptor forExpand
Toward an Understanding of the Correlates of Protective Immunity to HIV Infection
TLDR
Investigation of HIV-specific immune responses in HIV-negative individuals who have been exposed to the virus multiple times suggests that natural immune responses to HIV may be protective in rare individuals. Expand
Latent reservoirs of HIV: obstacles to the eradication of virus.
  • T. Chun, A. Fauci
  • Biology, Medicine
  • Proceedings of the National Academy of Sciences of the United States of America
  • 1999
TLDR
Recent developments in studies of the latent reservoir of HIV in patients receiving HAART are discussed and implications for the long-term treatment of infected individuals and eradication of the infection are discussed. Expand
...
1
2
3
4
5
...